ATE202113T1 - Verfahren zur herstellung von 2'-deoxy-2',2'- difluornukleosiden - Google Patents

Verfahren zur herstellung von 2'-deoxy-2',2'- difluornukleosiden

Info

Publication number
ATE202113T1
ATE202113T1 AT95201846T AT95201846T ATE202113T1 AT E202113 T1 ATE202113 T1 AT E202113T1 AT 95201846 T AT95201846 T AT 95201846T AT 95201846 T AT95201846 T AT 95201846T AT E202113 T1 ATE202113 T1 AT E202113T1
Authority
AT
Austria
Prior art keywords
deoxy
producing
difluoronucleosides
difluorenucleosides
erythro
Prior art date
Application number
AT95201846T
Other languages
English (en)
Inventor
Ta Sen Chou
Perry Clark Heath
Lawrence Edward Patterson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE202113T1 publication Critical patent/ATE202113T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Epoxy Compounds (AREA)
AT95201846T 1987-08-28 1988-08-22 Verfahren zur herstellung von 2'-deoxy-2',2'- difluornukleosiden ATE202113T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9072587A 1987-08-28 1987-08-28

Publications (1)

Publication Number Publication Date
ATE202113T1 true ATE202113T1 (de) 2001-06-15

Family

ID=22224017

Family Applications (4)

Application Number Title Priority Date Filing Date
AT94202041T ATE179713T1 (de) 1987-08-28 1988-08-22 Verfahren zur selektiven isolierung von beta-2'- desoxy-2'2'-difluorocytidin oder seiner salze
AT88307750T ATE164847T1 (de) 1987-08-28 1988-08-22 Verfahren zur herstellung von zwischenverbindungen verwendbar in der herstellung von 2',2'-difluoronucleosiden
AT95201846T ATE202113T1 (de) 1987-08-28 1988-08-22 Verfahren zur herstellung von 2'-deoxy-2',2'- difluornukleosiden
AT95201845T ATE217009T1 (de) 1987-08-28 1988-08-22 Stereoselektives verfahren zur herstellung von geschützten 2',2'-difluorlactonen

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT94202041T ATE179713T1 (de) 1987-08-28 1988-08-22 Verfahren zur selektiven isolierung von beta-2'- desoxy-2'2'-difluorocytidin oder seiner salze
AT88307750T ATE164847T1 (de) 1987-08-28 1988-08-22 Verfahren zur herstellung von zwischenverbindungen verwendbar in der herstellung von 2',2'-difluoronucleosiden

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT95201845T ATE217009T1 (de) 1987-08-28 1988-08-22 Stereoselektives verfahren zur herstellung von geschützten 2',2'-difluorlactonen

Country Status (11)

Country Link
EP (4) EP0688783B1 (de)
JP (5) JP2738540B2 (de)
KR (1) KR970002659B1 (de)
AT (4) ATE179713T1 (de)
CA (1) CA1324128C (de)
DE (4) DE3856527T2 (de)
ES (4) ES2113845T3 (de)
GR (1) GR3026611T3 (de)
HU (3) HU202249B (de)
IE (1) IE81131B1 (de)
IL (1) IL87517A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2012129A1 (en) * 1989-03-20 1990-09-20 Ramakrishnan Nagarajan Recovery of difluoro sugar
US5256798A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
US5401861A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
US5256797A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for separating 2-deoxy-2,2-difluoro-D-ribofuranosyl alkylsulfonate anomers
US5252756A (en) * 1992-06-22 1993-10-12 Eli Lilly And Company Process for preparing beta-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-arylsulfonates
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
US5559222A (en) * 1995-02-03 1996-09-24 Eli Lilly And Company Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
WO1997021719A1 (en) 1995-12-13 1997-06-19 Eli Lilly And Company α, α-DIFLUORO-β-HYDROXY THIOL ESTERS AND THEIR SYNTHESIS
KR100578616B1 (ko) * 2004-07-23 2006-05-10 한미약품 주식회사 D-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법
US8193354B2 (en) * 2005-10-28 2012-06-05 Arch Pharmalabs Limited Process for preparation of Gemcitabine hydrochloride
WO2007069838A1 (en) * 2005-12-14 2007-06-21 Dong-A Pharm.Co., Ltd. A manufacturing process of 2',2'-difluoronucleoside and intermediate
KR100741310B1 (ko) * 2006-08-01 2007-08-01 (주) 유일팜테크 젬시타빈의 합성에 유용한 신규한나프탈렌-2-카르복실레이트 유도체와 그의 제조방법
US7994310B2 (en) * 2007-03-23 2011-08-09 Dongwoo Syntech Co., Ltd. Process for preparing 2′-deoxy-2′, 2′-difluorocytidine
CA2727813A1 (en) 2008-06-12 2009-12-17 Scinopharm Taiwan, Ltd. Crystalline polymorphs of gemcitabine base
GB0812895D0 (en) * 2008-07-15 2008-08-20 Glycom As Crystalline carbohydrate derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
CA1264738A (en) * 1984-12-04 1990-01-23 Eli Lilly And Company Treatment of tumors in mammals
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents

Also Published As

Publication number Publication date
IL87517A (en) 1993-05-13
DE3856158D1 (de) 1998-05-14
JPS6471894A (en) 1989-03-16
IE882608L (en) 1989-02-28
ATE179713T1 (de) 1999-05-15
JP2899576B2 (ja) 1999-06-02
EP0688783A1 (de) 1995-12-27
EP0688782B1 (de) 2002-05-02
JPH1072457A (ja) 1998-03-17
ES2131152T3 (es) 1999-07-16
IE81131B1 (en) 2000-03-22
EP0306190A3 (de) 1991-11-21
EP0688782A1 (de) 1995-12-27
HU202249B (en) 1991-02-28
DE3856527D1 (de) 2002-06-06
EP0306190B1 (de) 1998-04-08
HUT47590A (en) 1989-03-28
DE3856330D1 (de) 1999-06-10
ES2176279T3 (es) 2002-12-01
JP2899577B2 (ja) 1999-06-02
DE3856330T2 (de) 1999-09-30
KR890003794A (ko) 1989-04-18
ATE164847T1 (de) 1998-04-15
EP0688783B1 (de) 2001-06-13
GR3026611T3 (en) 1998-07-31
IL87517A0 (en) 1989-01-31
JPH1072483A (ja) 1998-03-17
HU206886B (en) 1993-01-28
DE3856477T2 (de) 2001-11-08
JP2810034B2 (ja) 1998-10-15
JP2738540B2 (ja) 1998-04-08
EP0630905B1 (de) 1999-05-06
ATE217009T1 (de) 2002-05-15
JP2777359B2 (ja) 1998-07-16
DE3856158T2 (de) 1998-08-20
HU906268D0 (en) 1991-03-28
EP0630905A1 (de) 1994-12-28
HU9201768D0 (en) 1992-08-28
DE3856477D1 (de) 2001-07-19
CA1324128C (en) 1993-11-09
DE3856527T2 (de) 2002-10-31
KR970002659B1 (ko) 1997-03-07
JPH1072484A (ja) 1998-03-17
ES2157289T3 (es) 2001-08-16
JPH1081696A (ja) 1998-03-31
ES2113845T3 (es) 1998-05-16
EP0306190A2 (de) 1989-03-08

Similar Documents

Publication Publication Date Title
ATE202113T1 (de) Verfahren zur herstellung von 2'-deoxy-2',2'- difluornukleosiden
ATA245485A (de) Verfahren zur herstellung von neuen dihydropyridincarbonsaeure-derivaten
ATE126223T1 (de) Verfahren zur herstellung von ascorbinsäure.
DE3883408D1 (de) Verfahren zur Herstellung von Avermectinen und die verwendeten Kulturen.
DE3862306D1 (de) Verfahren zur elektrochemischen herstellung von carbonsaeuren.
DE3882723D1 (de) Verfahren zur herstellung von enzymelektroden.
DE3784988D1 (de) Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686.
DE3787773D1 (de) Zum Abbau von Glycosaminoglycan fähige Enzymzusammensetzung und Verfahren zur Herstellung dieser Zusammensetzung.
DE3863378D1 (de) Verfahren zur herstellung von koks hoher qualitaet.
DE3768148D1 (de) Verfahren zur herstellung von carbonsaeuren.
AT359191B (de) Verfahren zur herstellung von neuen derivaten des daunorubicins
DE3883911D1 (de) Verfahren zur Herstellung von Orotsäure durch Fermentierung.
DE3855002D1 (de) Verfahren zur Herstellung von Dodecahydro-3a,6,6,9a-tetramethylnaphto(2,1-b)furan
DE3785266D1 (de) Stamm zur massenproduktion von epsilon-poly-l-lysin, methode, um diesen stamm zu gebrauchen, und methode zur herstellung von epsilon-poly-l-lysin.
DE3585646D1 (de) Fermentationsverfahren zur herstellung von karbonsaeurealkylestern.
DE3880072D1 (de) N-phenyl-2,2,6,6-tetrahalogencyclohexanimin und verfahren zur herstellung von derivaten des 2,2,6,6-tetrahalogencyclohexanimins und von derivaten des 2,6-dihalogenanilins.
ATE118551T1 (de) Verfahren zur herstellung von s-2,2-r1,r2-1,3- dioxolan-4-methanol.
DE68927132D1 (de) Verfahren zur Herstellung von Lactonen
DE3868160D1 (de) Verfahren zur herstellung von carbonsaeuren.
DE3767234D1 (de) Verfahren zur herstellung von carbonsaeurehalogeniden.
DE3583794D1 (de) Verfahren zur herstellung von bestaendigen pharmazeutischen zusammensetzungen von prostaglandin-e-derivaten und/oder ihren 15r-formen.
DE69225610D1 (de) Verfahren zur herstellung von avermectin und kulturen dafür
ATE58140T1 (de) Verfahren zur herstellung eines lactons.
DE3867339D1 (de) Verfahren zur herstellung von salzen des aminomalonsaeuredinitrils.
AT378204B (de) Verfahren zur herstellung von glucoseisomerase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee